CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

C. M. Banki, G. Bissette, M. Arato, L. O'Connor, Charles Nemeroff

Research output: Contribution to journalArticle

298 Citations (Scopus)

Abstract

To further investigate the hypothesis that hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with depression may be mediated by hypersecretion of corticotropin-releasing factor (CRF), the authors measured CRF-like immunoreactivity in CSF samples from 138 neurological control, 54 depressed, and 27 nondepressed (23 schizophrenic and four manic) subjects. The CSF CRF concentration was markedly higher (almost twofold) in depressed patients than in control subjects and nondepressed psychiatric patients. The concentration of CSF CRF was slightly but significantly higher in schizophrenic patients than in control subjects. These findings provide further support for the hypothesis that CRF hypersecretion occurs in major depression.

Original languageEnglish
Pages (from-to)873-877
Number of pages5
JournalAmerican Journal of Psychiatry
Volume144
Issue number7
StatePublished - Sep 1 1987
Externally publishedYes

Fingerprint

Corticotropin-Releasing Hormone
Schizophrenia
Depression
Psychiatry

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. / Banki, C. M.; Bissette, G.; Arato, M.; O'Connor, L.; Nemeroff, Charles.

In: American Journal of Psychiatry, Vol. 144, No. 7, 01.09.1987, p. 873-877.

Research output: Contribution to journalArticle

Banki, C. M. ; Bissette, G. ; Arato, M. ; O'Connor, L. ; Nemeroff, Charles. / CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. In: American Journal of Psychiatry. 1987 ; Vol. 144, No. 7. pp. 873-877.
@article{1ee0f7429c4d446aa0d07cb7a6e39c6f,
title = "CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia",
abstract = "To further investigate the hypothesis that hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with depression may be mediated by hypersecretion of corticotropin-releasing factor (CRF), the authors measured CRF-like immunoreactivity in CSF samples from 138 neurological control, 54 depressed, and 27 nondepressed (23 schizophrenic and four manic) subjects. The CSF CRF concentration was markedly higher (almost twofold) in depressed patients than in control subjects and nondepressed psychiatric patients. The concentration of CSF CRF was slightly but significantly higher in schizophrenic patients than in control subjects. These findings provide further support for the hypothesis that CRF hypersecretion occurs in major depression.",
author = "Banki, {C. M.} and G. Bissette and M. Arato and L. O'Connor and Charles Nemeroff",
year = "1987",
month = "9",
day = "1",
language = "English",
volume = "144",
pages = "873--877",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "7",

}

TY - JOUR

T1 - CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

AU - Banki, C. M.

AU - Bissette, G.

AU - Arato, M.

AU - O'Connor, L.

AU - Nemeroff, Charles

PY - 1987/9/1

Y1 - 1987/9/1

N2 - To further investigate the hypothesis that hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with depression may be mediated by hypersecretion of corticotropin-releasing factor (CRF), the authors measured CRF-like immunoreactivity in CSF samples from 138 neurological control, 54 depressed, and 27 nondepressed (23 schizophrenic and four manic) subjects. The CSF CRF concentration was markedly higher (almost twofold) in depressed patients than in control subjects and nondepressed psychiatric patients. The concentration of CSF CRF was slightly but significantly higher in schizophrenic patients than in control subjects. These findings provide further support for the hypothesis that CRF hypersecretion occurs in major depression.

AB - To further investigate the hypothesis that hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with depression may be mediated by hypersecretion of corticotropin-releasing factor (CRF), the authors measured CRF-like immunoreactivity in CSF samples from 138 neurological control, 54 depressed, and 27 nondepressed (23 schizophrenic and four manic) subjects. The CSF CRF concentration was markedly higher (almost twofold) in depressed patients than in control subjects and nondepressed psychiatric patients. The concentration of CSF CRF was slightly but significantly higher in schizophrenic patients than in control subjects. These findings provide further support for the hypothesis that CRF hypersecretion occurs in major depression.

UR - http://www.scopus.com/inward/record.url?scp=0023251249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023251249&partnerID=8YFLogxK

M3 - Article

C2 - 3496802

AN - SCOPUS:0023251249

VL - 144

SP - 873

EP - 877

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 7

ER -